WT1 PEPTIDE-BASED CANCER IMMUNOTHERAPY

被引：0
|
作者：
Sugiyama, H. [1 ]
机构：
[1] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka 565, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] WT1 PEPTIDE-BASED CANCER IMMUNOTHERAPY
    Sugiyama, Haruo
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1017 - 1018
  • [2] WT1 peptide-based immunotherapy for patients with lung cancer: Report of two cases
    Tsuboi, A
    Oka, Y
    Osaki, T
    Kumagai, T
    Tachibana, I
    Hayashi, S
    Murakami, M
    Nakajima, H
    Elisseeva, OA
    Fei, W
    Masuda, T
    Yasukawa, M
    Oji, Y
    Kawakami, M
    Hosen, N
    Ikegame, K
    Yoshihara, S
    Udaka, K
    Nakatsuka, S
    Aozasa, K
    Kawase, L
    Sugiyama, H
    MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (03) : 175 - 184
  • [3] Immunomonitoring of rare cancer patients treated with WT1 Trio peptide-based cancer immunotherapy
    Hayashi, Sae
    Oji, Yusuke
    Kagawa, Naoki
    Arita, Hideyuki
    Shintani, Yasushi
    Takeda, Yoshito
    Morii, Eiichi
    Hamada, Kenichiro
    Shimazu, Kenzo
    Suzuki, Motoyuki
    Imanishi, Rin
    Sugiyama, Haruo
    CANCER SCIENCE, 2018, 109 : 1275 - 1275
  • [4] WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies
    Oji, Yusuke
    Inoue, Masayoshi
    Takeda, Yoshito
    Hosen, Naoki
    Shintani, Yasushi
    Kawakami, Manabu
    Harada, Takuya
    Murakami, Yui
    Iwai, Miki
    Fukuda, Mari
    Nishida, Sumiyuki
    Nakata, Jun
    Nakae, Yoshiki
    Takashima, Satoshi
    Shirakata, Toshiaki
    Nakajima, Hiroko
    Hasegawa, Kana
    Kida, Hiroshi
    Kijima, Takashi
    Morimoto, Soyoko
    Fujiki, Fumihiro
    Tsuboi, Akihiro
    Morii, Eiichi
    Morita, Satoshi
    Sakamoto, Junichi
    Kumanogoh, Atsushi
    Oka, Yoshihiro
    Okumura, Meinoshin
    Sugiyama, Haruo
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (11) : 2375 - 2382
  • [5] Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy
    Kanegae, Mizuki
    Kagawa, Naoki
    Kijima, Noriyuki
    Hirayama, Ryuichi
    Shimokado, Haruka
    Nishida, Sumiyuki
    Hosen, Naoki
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Sugiyama, Haruo
    Kishima, Haruhiko
    Oji, Yusuke
    CANCER SCIENCE, 2022, 113 : 524 - 524
  • [6] WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
    Oji, Yusuke
    Kagawa, Naoki
    Arita, Hideyuki
    Naka, Norifumi
    Hamada, Ken-ichiro
    Outani, Hidetatsu
    Shintani, Yasushi
    Takeda, Yoshito
    Morii, Eiichi
    Shimazu, Kenzo
    Suzuki, Motoyuki
    Nishida, Sumiyuki
    Nakata, Jun
    Tsuboi, Akihiro
    Iwai, Miki
    Hayashi, Sae
    Imanishi, Rin
    Ikejima, Sayaka
    Kanegae, Mizuki
    Iwamoto, Masahiro
    Ikeda, Mayu
    Yagi, Kento
    Shimokado, Haruka
    Nakajima, Hiroko
    Hasegawa, Kana
    Morimoto, Soyoko
    Fujiki, Fumihiro
    Nagahara, Akira
    Tanemura, Atsushi
    Ueda, Yutaka
    Mizushima, Tsunekazu
    Ohmi, Masato
    Ishida, Takayuki
    Fujimoto, Manabu
    Nonomura, Norio
    Kimura, Tadashi
    Inohara, Hidenori
    Okada, Seiji
    Kishima, Haruhiko
    Hosen, Naoki
    Kumanogoh, Atsushi
    Oka, Yoshihiro
    Sugiyama, Haruo
    CANCERS, 2023, 15 (02)
  • [7] WT1 Peptide Immunotherapy for Cancer in Children and Young Adults
    Hashii, Yoshiko
    Sato, Emiko
    Ohta, Hideaki
    Oka, Yoshihiro
    Sugiyama, Haruo
    Ozono, Keiichi
    PEDIATRIC BLOOD & CANCER, 2010, 55 (02) : 352 - 355
  • [8] Peptide-based immunotherapy of cancer
    Rammensee, H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S12 - S12
  • [9] Cancer Antigen WT1 Protein-Derived Peptide-Based Treatment of Cancer - Toward the Further Development
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Fujiki, Fumihiro
    Shirakata, Toshiaki
    Nishida, Sumiyuki
    Hosen, Naoki
    Nakajima, Hiroko
    Li, Zheyu
    Kawase, Ichiro
    Oji, Yusuke
    Sugiyama, Haruo
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (29) : 3052 - 3061
  • [10] WT1 Peptide Vaccine as a Paradigm for "Cancer Antigen-Derived Peptide"-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Fujiki, Fumihiro
    Li, Zheyu
    Nakajima, Hiroko
    Hosen, Naoki
    Shirakata, Toshiaki
    Nishida, Sumiyuki
    Oji, Yusuke
    Kawase, Ichiro
    Sugiyama, Haruo
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (07) : 787 - 797
12345